Singapore Health Services Pte Ltd 2020 AR2
The report highlights SingHealth Duke-NUS Academic Medical Centre's achievements and clinical, research, and educational milestones for the 2019/2020 fiscal year. It details the organization's extensive frontline response to the COVID-19 pandemic, including diagnostic breakthroughs, vaccine collaborations, and protective device innovations. The report also outlines key infrastructure developments, such as the opening of Outram Community Hospital and the groundbreaking of the Elective Care Centre. Additionally, it showcases significant research achievements, including Singapore's largest biotech deal with Boehringer Ingelheim, and details philanthropic contributions that support patient care, education, and research.
Company: Singapore Health Services Pte Ltd
Sector: Healthcare & social services
Country: Singapore
Year: 2020
Type: AR2
Pages: 43
Singapore Health Services Pte Ltd
The report highlights SingHealth Duke-NUS Academic Medical Centre's achievements and clinical, research, and educational milestones for the 2019/2020 fiscal year. It details the organization's extensive frontline response to the COVID-19 pandemic, including diagnostic breakthroughs, vaccine collaborations, and protective device innovations. The report also outlines key infrastructure developments, such as the opening of Outram Community Hospital and the groundbreaking of the Elective Care Centre. Additionally, it showcases significant research achievements, including Singapore's largest biotech deal with Boehringer Ingelheim, and details philanthropic contributions that support patient care, education, and research.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Apr 1, 2019 - Mar 31, 2020
Fiscal Year
2020
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Employees